The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs

被引:11
|
作者
Nicze, Michal [1 ]
Borowka, Maciej [1 ]
Dec, Adrianna [1 ]
Niemiec, Aleksandra [1 ]
Buldak, Lukasz [1 ]
Okopien, Boguslaw [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Internal Med & Clin Pharmacol, Medykow 18, PL-40752 Katowice, Poland
关键词
peptide- and protein-based drug; oral drug absorption; permeation enhancers; hydrogels; microneedles; semaglutide; octreotide; desmopressin; cyclosporine; CELL-PENETRATING PEPTIDES; CYCLOSPORINE-A; IN-VITRO; CARDIOVASCULAR OUTCOMES; GASTROINTESTINAL MUCUS; INTESTINAL-ABSORPTION; TRYPSIN-INHIBITOR; TIGHT JUNCTIONS; HUMAN INSULIN; NANOPARTICLES;
D O I
10.3390/ijms25020815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drugs based on peptides and proteins (PPs) have been widely used in medicine, beginning with insulin therapy in patients with diabetes mellitus over a century ago. Although the oral route of drug administration is the preferred one by the vast majority of patients and improves compliance, medications of this kind due to their specific chemical structure are typically delivered parenterally, which ensures optimal bioavailability. In order to overcome issues connected with oral absorption of PPs such as their instability depending on digestive enzymes and pH changes in the gastrointestinal (GI) system on the one hand, but also their limited permeability across physiological barriers (mucus and epithelium) on the other hand, scientists have been strenuously searching for novel delivery methods enabling peptide and protein drugs (PPDs) to be administered enterally. These include utilization of different nanoparticles, transport channels, substances enhancing permeation, chemical modifications, hydrogels, microneedles, microemulsion, proteolytic enzyme inhibitors, and cell-penetrating peptides, all of which are extensively discussed in this review. Furthermore, this article highlights oral PP therapeutics both previously used in therapy and currently available on the medical market.
引用
收藏
页数:29
相关论文
共 50 条
  • [41] Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery
    Boisguerin, Prisca
    Konate, Karidia
    Josse, Emilie
    Vives, Eric
    Deshayes, Sebastien
    BIOMEDICINES, 2021, 9 (05)
  • [42] Peptide-based nanoparticles for delivery of siRNA: "Raspberry Flavor"
    Deshayes, Sebastien
    Divita, Gilles
    CHIMICA OGGI-CHEMISTRY TODAY, 2013, 31 (02) : 2 - 5
  • [43] Recent developments in peptide-based nucleic acid delivery
    Veldhoen, Sandra
    Laufer, Sandra D.
    Restle, Tobias
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2008, 9 (07) : 1276 - 1320
  • [44] Peptide-Based and Polypeptide-Based Gene Delivery Systems
    Chen, Jie
    Guan, Xiuwen
    Hu, Yingying
    Tian, Huayu
    Chen, Xuesi
    TOPICS IN CURRENT CHEMISTRY, 2017, 375 (02)
  • [45] Peptide-based vectors for blood-brain barrier targeting and delivery of drugs to the central nervous system
    Vlieghe, Patrick
    Khrestchatisky, Michel
    THERAPEUTIC DELIVERY, 2010, 1 (04) : 489 - 494
  • [46] An Effective Peptide-Based Platform for Efficient Exosomal Loading and Cellular Delivery of a microRNA
    Hade, Mangesh D.
    Suire, Caitlin N.
    Suo, Zucai
    ACS APPLIED MATERIALS & INTERFACES, 2023, 15 (03) : 3851 - 3866
  • [47] Peptide-Based Delivery of Oligonucleotides Across Blood-Brain Barrier Model
    Srimanee, Artita
    Regberg, Jakob
    Hallbrink, Mattias
    Kurrikoff, Kaido
    Veiman, Kadi-Liis
    Vajragupta, Opa
    Langel, Ulo
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2014, 20 (02) : 169 - 178
  • [48] New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids
    Arukuusk, Piret
    Paernaste, Ly
    Oskolkov, Nikita
    Copolovici, Dana-Maria
    Margus, Helerin
    Padari, Kaert
    Moell, Kaidi
    Maslovskaja, Julia
    Tegova, Radi
    Kivi, Gaily
    Tover, Andres
    Pooga, Margus
    Ustav, Mart
    Langel, Ulo
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2013, 1828 (05): : 1365 - 1373
  • [49] Peptide-based immunotherapy for multiple myeloma: Current approaches
    Zhou, Fu-ling
    Meng, Shan
    Zhang, Wang-gang
    Wei, Yong-chang
    Cao, Xing-mei
    Bai, Gai-gai
    Wang, Bai-yan
    VACCINE, 2010, 28 (37) : 5939 - 5946
  • [50] Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability
    Verma, Saurabh
    Goand, Umesh K.
    Husain, Athar
    Katekar, Roshan A.
    Garg, Richa
    Gayen, Jiaur R.
    DRUG DEVELOPMENT RESEARCH, 2021, 82 (07) : 927 - 944